CRISPR THERAPEUTICS AG revenue breakdown overview

CRISPR THERAPEUTICS AG revenue for the last year amounted to 777.97 M MXN, the most of which — 777.97 M MXN — came from its highest performing source at the moment, Gene-based Medicines, the year earlier bringing 6.30 B MXN. The greatest contribution to the revenue figure was made by Switzerland and United States — last year it brought CRISPR THERAPEUTICS AG 777.97 M MXN, and the year before that — 6.30 B MXN.